Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
FLAG tag Peptide (DYKDDDDK): Precision Tag for Protein Purif
2026-04-21
The FLAG tag Peptide (DYKDDDDK) enables highly specific, gentle purification and detection of recombinant proteins. Its unique sequence and enterokinase-cleavage site optimize elution and workflow flexibility. This article details quantitative benchmarks, best-use protocols, and evidence-based limitations, supporting reliable application in molecular biology.
-
THZ1: Covalent CDK7 Inhibitor Workflows for Cancer Biology
2026-04-20
THZ1, a potent covalent CDK7 inhibitor from APExBIO, unlocks precision transcriptional control and robust antiproliferative effects in cancer models, particularly T-cell acute lymphoblastic leukemia (T-ALL). This article translates recent mechanistic and workflow insights into actionable experimental protocols, troubleshooting guidance, and practical assay enhancements.
-
Probenecid for Multidrug Resistance and Neuroprotection Rese
2026-04-20
Probenecid (4-(dipropylsulfamoyl)benzoic acid) stands out as a dual-action biochemical tool for overcoming multidrug resistance in tumor models and mitigating neuronal damage in ischemia/reperfusion injury. This guide translates cutting-edge mechanistic evidence and bench-proven workflows into actionable protocols, helping researchers maximize assay integrity and reproducibility.
-
Carfilzomib (PR-171) for Proteasome Inhibition in Cancer Ass
2026-04-19
Carfilzomib (PR-171) offers bench scientists an irreversible, nanomolar-potency tool for dissecting proteasome-mediated cell death pathways. This guide translates cutting-edge preclinical findings and troubleshooting insights into actionable workflows, helping you optimize apoptosis induction and proteasome inhibition in diverse cancer research contexts.
-
AICAR and AMPK: Precision Tools for Macrophage Polarization
2026-04-18
Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) uniquely enables targeted AMPK activation to dissect macrophage polarization and inflammation in metabolic disease models. This in-depth review draws on the latest mechanistic evidence and practical assay insights.
-
SC 79: Advanced Akt Activation for Neuroprotection & Metabol
2026-04-17
Explore how SC 79, a potent Akt activator, enables groundbreaking research in neuroprotection and metabolic disease. This article offers a unique, assay-driven perspective on SC 79’s mechanistic advantages and translational potential.
-
CDC42 Regulates HBV Entry via NTCP Trafficking and Macropino
2026-04-16
Cui et al. reveal that CDC42, a Rho GTPase, facilitates hepatitis B virus (HBV) entry into hepatocytes through Rab11-dependent NTCP trafficking and by promoting macropinocytosis, independent of the canonical clathrin-mediated pathway. These insights highlight new mechanistic targets for antiviral strategies and deepen our understanding of HBV–host interactions.
-
HBV G1896A Mutation Drives HCC Malignancy via ER Stress and
2026-04-15
This study reveals that the hepatitis B virus (HBV) precore G1896A mutation promotes hepatocellular carcinoma (HCC) progression by activating ER stress and enhancing aerobic glycolysis. The findings elucidate a mechanistic axis involving PERK-ATF4 signaling and PFKFB3 transcription, highlighting new targets for HCC intervention.
-
Angiotensin 1/2 (1-6): Precision Modulation in Cardiovascula
2026-04-14
Discover how Angiotensin 1/2 (1-6) empowers advanced renin-angiotensin system research. This article uniquely dissects its molecular selectivity and recent virology intersections, offering evidence-based guidance for cardiovascular and renal assay optimization.
-
WZ4003 (SKU B1374): Reliable NUAK1/2 Inhibition for Cell Ass
2026-04-13
This article delivers scenario-driven guidance for optimizing cell viability and proliferation assays with WZ4003 (SKU B1374), a highly selective NUAK1/2 inhibitor. Drawing on recent peer-reviewed data and practical workflow experience, it addresses protocol optimization, data interpretation, and vendor reliability, enabling researchers to achieve reproducible, high-sensitivity results in cancer and neurodegeneration research.
-
Phenacetin in Advanced Pharmacokinetic Studies: Protocol & P
2026-04-13
Phenacetin (N-(4-ethoxyphenyl)acetamide) is a benchmark probe for human-relevant pharmacokinetic studies, now empowered by state-of-the-art hiPSC-derived intestinal organoid models. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and evidence-driven tips for maximizing assay reliability with APExBIO's high-purity Phenacetin.
-
Dual-Action Kinase Inhibitors Modulate p38α MAPK Dephosphory
2026-04-12
The reference study reveals that certain kinase inhibitors, including those targeting p38α MAPK, not only block kinase activity but also promote its dephosphorylation by altering activation loop conformation. This dual-action mechanism provides a new strategy to enhance specificity and potency in inflammation and cytokine signaling research.
-
ER Stress and Cytokine Storm Drive Prometastatic Tumor State
2026-04-12
Conod et al. (2022) uncover how tumor cells surviving near-lethal stress adopt stable pro-metastatic phenotypes, termed PAMEs, via ER stress, nuclear reprogramming, and cytokine signaling. These findings clarify the origins of metastatic capacity in primary tumors and suggest new routes for therapeutic intervention.
-
Applied Cardiovascular Research with (-)-Norepinephrine (+)-
2026-04-11
(-)-Norepinephrine (+)-bitartrate empowers researchers to precisely induce and dissect adrenergic signaling in cardiovascular models with reproducible, high-fidelity outcomes. This article delivers actionable protocols, evidence-based troubleshooting, and comparative insights to optimize experimental workflows using APExBIO’s rigorously validated reagent.
-
Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S
2026-04-11
The Lipid Peroxidation (MDA) Assay Kit empowers researchers to quantify malondialdehyde with high sensitivity, supporting robust studies on oxidative stress and ferroptosis. Its dual detection modes and built-in antioxidants make it a versatile tool for troubleshooting and advanced lipid peroxidation measurement across diverse biological models.